449 related articles for article (PubMed ID: 11953991)
1. Suppression of collagen-induced arthritis by single administration of poly(lactic-co-glycolic acid) nanoparticles entrapping type II collagen: a novel treatment strategy for induction of oral tolerance.
Kim WU; Lee WK; Ryoo JW; Kim SH; Kim J; Youn J; Min SY; Bae EY; Hwang SY; Park SH; Cho CS; Park JS; Kim HY
Arthritis Rheum; 2002 Apr; 46(4):1109-20. PubMed ID: 11953991
[TBL] [Abstract][Full Text] [Related]
2. Antigen-induced, tolerogenic CD11c+,CD11b+ dendritic cells are abundant in Peyer's patches during the induction of oral tolerance to type II collagen and suppress experimental collagen-induced arthritis.
Min SY; Park KS; Cho ML; Kang JW; Cho YG; Hwang SY; Park MJ; Yoon CH; Min JK; Lee SH; Park SH; Kim HY
Arthritis Rheum; 2006 Mar; 54(3):887-98. PubMed ID: 16508971
[TBL] [Abstract][Full Text] [Related]
3. Oral administration of type II collagen suppresses pro-inflammatory mediator production by synoviocytes in rats with adjuvant arthritis.
Ding CH; Li Q; Xiong ZY; Zhou AW; Jones G; Xu SY
Clin Exp Immunol; 2003 Jun; 132(3):416-23. PubMed ID: 12780687
[TBL] [Abstract][Full Text] [Related]
4. Induction of IL-10-producing CD4+CD25+ T cells in animal model of collagen-induced arthritis by oral administration of type II collagen.
Min SY; Hwang SY; Park KS; Lee JS; Lee KE; Kim KW; Jung YO; Koh HJ; Do JH; Kim H; Kim HY
Arthritis Res Ther; 2004; 6(3):R213-9. PubMed ID: 15142267
[TBL] [Abstract][Full Text] [Related]
5. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.
Zhu P; Li XY; Wang HK; Jia JF; Zheng ZH; Ding J; Fan CM
Clin Immunol; 2007 Jan; 122(1):75-84. PubMed ID: 17045846
[TBL] [Abstract][Full Text] [Related]
6. Estrogen altered oral tolerance induction in type II collagen-induced murine arthritis.
Hosoda T; Mito N; Yoshino H; Sato K
Int Arch Allergy Immunol; 2004 Jan; 133(1):19-28. PubMed ID: 14646375
[TBL] [Abstract][Full Text] [Related]
7. Lactobacillus rhamnosus exopolysaccharide ameliorates arthritis induced by the systemic injection of collagen and lipopolysaccharide in DBA/1 mice.
Nowak B; Ciszek-Lenda M; Sróttek M; Gamian A; Kontny E; Górska-Frączek S; Marcinkiewicz J
Arch Immunol Ther Exp (Warsz); 2012 Jun; 60(3):211-20. PubMed ID: 22484803
[TBL] [Abstract][Full Text] [Related]
8. Preparation and characterization of biodegradable nanoparticles entrapping immunodominant peptide conjugated with PEG for oral tolerance induction.
Lee WK; Park JY; Jung S; Yang CW; Kim WU; Kim HY; Park JH; Park JS
J Control Release; 2005 Jun; 105(1-2):77-88. PubMed ID: 15919128
[TBL] [Abstract][Full Text] [Related]
9. Indoleamine 2,3-dioxygenase-expressing dendritic cells are involved in the generation of CD4+CD25+ regulatory T cells in Peyer's patches in an orally tolerized, collagen-induced arthritis mouse model.
Park MJ; Min SY; Park KS; Cho YG; Cho ML; Jung YO; Park HS; Chang SH; Cho SG; Min JK; Park SH; Kim HY
Arthritis Res Ther; 2008; 10(1):R11. PubMed ID: 18221522
[TBL] [Abstract][Full Text] [Related]
10. Nanoparticles made of fluorescence-labelled Poly(L-lactide-co-glycolide): preparation, stability, and biocompatibility.
Weiss B; Schaefer UF; Zapp J; Lamprecht A; Stallmach A; Lehr CM
J Nanosci Nanotechnol; 2006; 6(9-10):3048-56. PubMed ID: 17048517
[TBL] [Abstract][Full Text] [Related]
11. Using poly(lactic-co-glycolic acid) microspheres to encapsulate plasmid of bone morphogenetic protein 2/polyethylenimine nanoparticles to promote bone formation in vitro and in vivo.
Qiao C; Zhang K; Jin H; Miao L; Shi C; Liu X; Yuan A; Liu J; Li D; Zheng C; Zhang G; Li X; Yang B; Sun H
Int J Nanomedicine; 2013; 8():2985-95. PubMed ID: 23990717
[TBL] [Abstract][Full Text] [Related]
12. Modulation of established murine collagen-induced arthritis by a single inoculation of short-term lipopolysaccharide-stimulated dendritic cells.
Salazar L; Aravena O; Abello P; Escobar A; Contreras-Levicoy J; Rojas-Colonelli N; Catalán D; Aguirre A; Zúñiga R; Pesce B; González C; Cepeda R; Cuchacovich M; Molina MC; Salazar-Onfray F; Delgado M; Toes RE; Aguillón JC
Ann Rheum Dis; 2008 Sep; 67(9):1235-41. PubMed ID: 18056756
[TBL] [Abstract][Full Text] [Related]
13. Redifferentiation of dedifferentiated bovine chondrocytes when cultured in vitro in a PLGA-collagen hybrid mesh.
Chen G; Sato T; Ushida T; Hirochika R; Tateishi T
FEBS Lett; 2003 May; 542(1-3):95-9. PubMed ID: 12729905
[TBL] [Abstract][Full Text] [Related]
14. Conjugation of drug to poly(D,L-lactic-co-glycolic acid) for controlled release from biodegradable microspheres.
Oh JE; Nam YS; Lee KH; Park TG
J Control Release; 1999 Feb; 57(3):269-80. PubMed ID: 9895414
[TBL] [Abstract][Full Text] [Related]
15. Formulation and evaluation of poly(lactic-co-glycolic acid) microspheres loaded with an altered collagen type II peptide for the treatment of rheumatoid arthritis.
He J; Li H; Liu C; Wang G; Ge L; Ma S; Huang L; Yan S; Xu X
J Microencapsul; 2015; 32(6):608-17. PubMed ID: 26190213
[TBL] [Abstract][Full Text] [Related]
16. MRI-assessed therapeutic effects of locally administered PLGA nanoparticles loaded with anti-inflammatory siRNA in a murine arthritis model.
te Boekhorst BC; Jensen LB; Colombo S; Varkouhi AK; Schiffelers RM; Lammers T; Storm G; Nielsen HM; Strijkers GJ; Foged C; Nicolay K
J Control Release; 2012 Aug; 161(3):772-80. PubMed ID: 22580113
[TBL] [Abstract][Full Text] [Related]
17. PLGA microspheres encapsulating siRNA anti-TNFalpha: efficient RNAi-mediated treatment of arthritic joints.
Présumey J; Salzano G; Courties G; Shires M; Ponchel F; Jorgensen C; Apparailly F; De Rosa G
Eur J Pharm Biopharm; 2012 Nov; 82(3):457-64. PubMed ID: 22922428
[TBL] [Abstract][Full Text] [Related]
18. Total abrogation of collagen II-induced arthritis and the B cell response to type II collagen using suboptimal doses of a topoisomerase II antagonist.
Verdrengh M; Jonsson IM; Zaether O; Bajtner E; Holmdahl R; Tarkowski A
Ann Rheum Dis; 2002 Sep; 61(9):829-31. PubMed ID: 12176810
[TBL] [Abstract][Full Text] [Related]
19. Loss of SH3 domain-binding protein 2 function suppresses bone destruction in tumor necrosis factor-driven and collagen-induced arthritis in mice.
Mukai T; Gallant R; Ishida S; Kittaka M; Yoshitaka T; Fox DA; Morita Y; Nishida K; Rottapel R; Ueki Y
Arthritis Rheumatol; 2015 Mar; 67(3):656-67. PubMed ID: 25470448
[TBL] [Abstract][Full Text] [Related]
20. Effect of type I collagen on the adhesion, proliferation, and osteoblastic gene expression of bone marrow-derived mesenchymal stem cells.
Liu G; Hu YY; Zhao JN; Wu SJ; Xiong Z; Lu R
Chin J Traumatol; 2004 Dec; 7(6):358-62. PubMed ID: 15566693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
